Keyphrases
Healthy Controls
100%
Rheumatoid Arthritis
100%
Rheumatoid Arthritis Patients
100%
Patient-controlled
100%
Systemic Lupus Erythematosus
100%
Systemic Lupus Erythematosus Patient
100%
EBNA1
100%
Epstein-Barr Virus
66%
Virus Proteins
33%
Early Antigen
33%
Autoantibodies
16%
Susceptible Individuals
16%
Clinical Criteria
16%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Connective Tissue Disease
16%
Virus Antigen
16%
Diagnostic Use
16%
Diagnostic Role
16%
Epstein-Barr nuclear Antigen
16%
EBNA1-IgA
16%
Immunology and Microbiology
Inflammatory Arthritis
100%
Immunoglobulin M
100%
Systemic Lupus Erythematosus
100%
Epstein Barr Virus
37%
Immunoglobulin A
37%
Monospecific Antibody
25%
Viral Protein
25%
Early Antigen
25%
Autoantibodies
12%
Connective Tissue
12%
Enzyme-Linked Immunosorbent Assay
12%
Immunoglobulin M Antibody
12%
Epstein Barr Virus Antigen
12%
Epstein-Barr Virus Nuclear Antigen 1
12%